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Nematode parasitesa b s t r a c t
The scale of the damage worldwide to human health, animal health and agricultural crops resulting from
parasitic nematodes, together with the paucity of treatments and the threat of developing resistance to
the limited set of widely-deployed chemical tools, underlines the urgent need to develop novel drugs and
chemicals to control nematode parasites. Robust chemical screens which can be automated are a key part
of that discovery process. Hitherto, the successful automation of nematode behaviours has been a bottle-
neck in the chemical discovery process. As the measurement of nematode motility can provide a direct
scalar readout of the activity of the neuromuscular system and an indirect measure of the health of
the animal, this omission is acute. Motility offers a useful assay for high-throughput, phenotypic drug/
chemical screening and several recent developments have helped realise, at least in part, the potential
of nematode-based drug screening. Here we review the challenges encountered in automating nematode
motility and some important developments in the application of machine vision, statistical imaging and
tracking approaches which enable the automated characterisation of nematode movement. Such devel-
opments facilitate automated screening for new drugs and chemicals aimed at controlling human and
animal nematode parasites (anthelmintics) and plant nematode parasites (nematicides).
 2014 The Authors. Published by Elsevier Ltd. on behalf of Australian Society for Parasitology Inc. This is
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Parasitic nematode worms present major challenges to human
health, the health and productivity of farm livestock as well as crop
plant productivity. Human parasitic nematodes infect about a third
of the world’s population, causing signiﬁcant morbidity (Hotez
et al., 2008). The scale of the veterinary anti-parasitic drug market
(Evans and Chapple, 2002) and the annual harvest damage result-
ing from plant parasitic nematodes (Nicol et al., 2011) mean that
new control chemicals are urgently required, a situation exacer-
bated in the case of nematodes that infest farm animals, where
growing resistance to existing treatments is a major problem
(Sutherland and Leathwick, 2011).
The shortage of new drugs and chemicals to combat nematode
parasites and the threat of resistance are driving the search for new
chemical leads. The most direct route to discovery is via nematode
phenotypic screening and for some species the large number of
worms that can be obtained facilitates such approaches. Although
current trends in drug discovery have shifted towards target-based
screening (Eder et al., 2014), phenotypic screens remain very suc-
cessful (Swinney and Anthony, 2011 ; Eder et al., 2014). However,
nematode phenotypic screening for new anthelmintic leads is cur-
rently severely limited by the rate at which the chemical impact on
nematode phenotype can be scored. Large-scale screens require a
simple readout and parameters of interest include animal death,
paralysis, impaired motility and failure at some crucial point in
the life cycle such as egg laying, hatching or moulting. Without
automated phenotyping, the researcher has no option but to score
manually. Even when scoring is straightforward, as with counting
moving versus immobile animals, the task is slow, tedious and
repetitive and is therefore subject to errors due to experimenter
fatigue. Even the most accurately performed manual scoring sys-
tems may still discard a lot of data, making antiparasitic actions
which affect behaviour without killing or totally paralysing the
worms impractical for drug discovery screens. The same argu-
ments apply to another area of drug discovery based on nematode
(Caenorhabditis elegans) models of human disease where genetic
models can be generated in a few weeks and the worms handled
using standard liquid handling techniques, including microﬂuidics
(Culetto and Sattelle, 2000; Kaletta and Hengartner, 2006). Once
again the promise of large-scale, chemical screening of such mod-
els is limited by the rate at which their (often subtle) phenotypes
can be assayed. Several approaches have been pursued in attempts
to deliver robust, automated assays of nematode behaviour. In this
review we ﬁrst consider the challenges faced, then address recent
progress in the ﬁeld of motility automation and ﬁnally suggest a
roadmap for the development of industry-standard, automated,
nematode phenotyping.2. The scale and urgency of the challenge to discover new
anthelmintics
Almost one third of the world’s population are infected with
helminth parasites (Hotez et al., 2008). Helminth infections such
as ascariasis, trichuriasis, strongyloidiasis, hookworm, liver ﬂuke
and intestinal ﬂukes are among the most important gastrointesti-
nal infections of humans with over 1 billion estimated to be suffer-
ing as a result of infection by one or more of these parasites
(McCarty et al., 2014). Precise estimates of the adverse effects of
nematodes on humans are hard to obtain, partly because of the dif-
ﬁculties in agreeing upon a robust and meaningful measure. How-
ever, a statistic known as Disability-Adjusted Life Years (DALYs),
the estimated number of healthy years lost to a disease, has
recently gained acceptance (Murray et al., 2012). The 2010 Global
Burden of Disease (GBD) study reported 807–1221 million peoplesuffer Ascaris lumbricoides infection, 604–795million have Trichuris
trichiura infection, and 576–740 million have hookworm (Necator
americanus, Ancylostoma duodenale) infection (Vos et al., 2012).
Although relatively few deaths were attributable to each species,
the loss of 5.6 million DALYs globally was attributable to these
infestations. The majority of DALYs were in Southeast Asia (47%)
and sub-Saharan Africa (23%). Despite the acknowledged limita-
tions of recording the impact of human parasitic nematodes in this
way, the fact remains that such numbers, coupled with the indirect
costs to agricultural productivity, amount to a serious human
health and agricultural problem. There is considerable commercial
incentive for developing new anthelmintics: the human health
antiparasitic drug market is around $0.5 billion/annum. Despite
these humanitarian and commercial incentives, it remains the case
that nearly all anthelmintics currently used to treat humans were
ﬁrst developed as veterinary products.
The veterinary economic burden resulting from internal and
external parasites is reﬂected in the scale of the global animal
health drug market - approximately $11 billion/annum (Evans
and Chapple, 2002). The problem of drug resistance in nematodes
of veterinary importance is also considerable (Kaplan, 2004). Crop
production can be severely compromised by nematode infections,
which result in an estimated $118 billion annual loss (Atkinson
et al., 2012). Such losses are disproportionately high in tropical
and sub-tropical climates, often in countries least able to cope with
major crop damage. For example, total crop production losses
attributable to nematodes have been estimated at 14.6% in devel-
oping countries compared to 8.8% in developed countries (Nicol
et al., 2011).3. The problem of resistance
The considerable challenges arising from human and animal
nematode parasites are compounded by the rise of drug/chemical
resistance, which has been recognised for many years (Waller,
1999), and has now developed to the point where there are cur-
rently no major livestock-producing areas in which either levam-
isole or the benzimidazoles can be considered highly effective
anthelmintics. Even more recently-introduced compounds such
as moxidectin are largely ineffective for certain species in all such
areas (Kaplan, 2004). There are also cases of resistance to monep-
antel, the most recently introduced anthelmintic, appearing in less
than 2 years of it being used on a New Zealand farm (Scott et al.,
2013).
Because resistance often applies to other members of the same
chemical family, we urgently need to discover new classes of
chemistry with potent anthelmintic actions. The quickest way to
ﬁnd new drugs and, simultaneously, new targets, is through phe-
notypic screening.4. High-throughput phenotypic screening for new
anthelmintics
In the search for novel human therapeutics, phenotypic screen-
ing is usually the domain of cell-based studies. This is justiﬁable
due to the ability to screen extremely large chemical libraries rela-
tively quickly. In contrast, whole organism screening, though desir-
able, is normally considered impractical, owing to high costs,
unacceptable animal numbers required and lengthy generation
times. When it comes to anthelmintics, target-based screening
using cell lines is a relatively new ﬁeld, though undoubtedly one
that will grow (Woods et al., 2011). However large-scale, whole
organism screening is not an obstacle when it comes to drug screen-
ing using nematodes. C. elegans, is a small (1 mm), self-fertilising,
free-living roundworm and its fast generation time – 3 days from
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itself well to the requirements of whole organism drug screening.
Not all, but a number of important human, animal and plant
parasitic nematodes can also be accessed in large enough numbers
to permit library-scale chemical screening. These include Toxocara
canis (the dog roundworm) (Ponce-Macotela et al., 2011),
A. lumbricoides (Fairbairn et al., 1961), Globodera rostochiensis
(Byrne et al., 2001), Ascaris suum (Urban andDouvres, 1981), Trichu-
ris muris (Fahmy, 1954), Ancylostoma ceylanicum (Reiss et al., 2007)
and Haemonchus contortus (Hubert and Kerboeuf, 1992). The use of
whole organisms in antiparasitic drug screening confers important
advantages. For example, cell-based assays do not fully replicate
many complex physiological systems whilewhole organism screens
have the beneﬁt of self-selecting compounds with favourable phar-
macokinetic parameters.
4.1. Lessons from using nematodes for human drug discovery
Although C. elegans is a free-living nematode, its similarity to
parasitic species suggests that it can be used as an approximate
model of parasitic worms. After all, it has been used successfully
to model many human diseases (Culetto and Sattelle, 2000;
Kaletta and Hengartner, 2006). The costs to a discovery pipeline
caused by the differences between free-living and parasitic worms
(false positives and negatives) are offset by the remarkable conve-
nience of using this species. When placed in a liquid, C. elegans
‘‘swim’’ using a stereotyped, rhythmic, oscillating body motion.
This motion is a direct readout of the neuromuscular system and
an indirect assay of the health of the animal. Conveniently, worms
continue to swim in liquid for long periods (indeed, worms can be
maintained in liquid culture), although potential changes in swim-
ming rate over time should be accounted for in using this as a
scored phenotype. Swimming therefore offers a useful measure-
ment, well-suited for the readily-scorable, phenotypic readout
required for a large-scale screen, as it is quantiﬁed as a simple sca-
lar number – the number of body bends per minute. The rate of
swimming (thrashing) can be measured manually, either using a
microscope and stopwatch or by observing ﬁlms of swimming
worms but in both cases this is laborious and error prone. Clearly,
this approach does not lend itself to large-scale screening – the
measurements need to be automated.
4.2. Parasitic nematodes and phenotypic screening: some biological
considerations
Endoparasitic nematodes are adapted to the environment inside
their host, and this often poses a challenge to maintaining them in
the laboratory. It would be impractical to list all the many proto-
cols for accomplishing this, but they include methods for hatching
T. canis (the dog roundworm) (Ponce-Macotela et al., 2011), A.
lumbricoides (Fairbairn et al., 1961) and G. rostochiensis (Byrne
et al., 2001). Protocols for the maintenance of A. suum from third
to fourth stage larvae (Urban and Douvres, 1981); as well as for iso-
lating larvae of T. muris (Fahmy, 1954) are available as are tech-
niques for culturing larvae of A. ceylanicum (Reiss et al., 2007)A
B
Fig. 1. Nematodes range in size and have diverse and complex behaviours. Movie
frames showing (A) rhythmic swimming (thrashing) movements seen in Caeno-
rhabditis elegans (scale indicates 1 mm) and (B) more complex movements recorded
from Trichuris muris (scale indicates 3 mm).and H. contortus (Hubert and Kerboeuf, 1992). Thus, some parasitic
nematodes can be maintained in conditions necessary for whole
organism assays of drugs.
4.3. Speciﬁcations for automated phenotyping and the challenge in
meeting them
Anthelmintic drug discovery assays need to rapidly report com-
pounds that kill worms, impair motility, or prevent the life cycle
from continuing. Only a small proportion of drugs will have any
such effect and the hit rate from even large chemical libraries
can be notoriously small. Such an assay must therefore be fast
enough to survey large chemical libraries in a very short time. Once
a hit has been obtained, a further optimisation step must then be
implemented in which a new chemical library is tested in order
to explore the chemical space around the original hit molecule.
All this highlights the demand for rapid, high-throughput assays.
Clearly, manual assays such as staining with Lugol’s iodine solution
and counting the number of eggs that have hatched, or scoring
worms manually for their motility, are not practical at such a scale
of throughput. Thus, the discovery of new anthelmintic drugs
requires some sort of automation. There are two aspects of assays
that could be automated, ﬁrst the detection of the drug’s actions on
the worm and secondly the automated handling of the nematodes.
The challenges are compounded by the range of size and diverse
activity of parasitic nematodes, many of which show complex pat-
terns of movement quite distinct from that seen in C. elegans
(Fig. 1).
4.4. Drug assay automation
An effective drug for treating nematode infestation is one that
reduces, or eliminates, the worm burden on the host. There are
several ways in which this can be done, but most drugs either halt
the progression of the life cycle, or kill/paralyse worms. Although
some parasitic worms can be maintained outside the host, often
this is difﬁcult, placing severe limitations on any automated
method. This means that automated assays are limited, in practice,
to ﬁnding drugs that either kill worms, or at least immobilize them.
In addition, the experimenter usually has a limited choice as to
which stages of the parasite can be conveniently studied in the lab-
oratory. So the task of automating drug discovery in this context is
often reduced to ﬁnding compounds that kill or immobilize a spe-
ciﬁc stage of the worm’s life cycle.
4.5. Can computers tell when a drug is affecting a worm?
There are several possible approaches to automation, and a good
introduction to the ﬁeld is to be found in Husson et al. (2013). An
obvious strategy is to try to emulate the way the assay is performed
manually. For example, WR Schafer’s lab have attempted to auto-
mate egg laying assays for the nematode C. elegans (Geng et al.,
2005) using a computer vision approach. The algorithm detected
the characteristic outline formed by an egg emerging from the body
wall of an adult worm. Using similar approaches, several laborato-
ries have over the past decade reported methods based on com-
puter vision for identifying nematodes in images or even
quantifying and identifying their behaviour (for review see
Buckingham and Sattelle, 2008). Nearly all of these studies were
aimed at C. elegans because of the scientiﬁc interest and medical
applications as potential human disease models. We will re-exam-
ine them here as potential starting points for extending such
approaches to parasitic nematodes and as case studies to assess
the promise, and pitfalls, in attempting to redeploy algorithms
developed for a free-living genetic model organism in assays using
parasitic nematodes. In this context, we pose the question, ‘‘Can the
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nematodes and are they sufﬁciently fast and robust to work in
high-throughput screens?’’
The promise of C. elegans as a model of human disease and as a
model of metazoan nervous system function in general is ham-
pered by a bottleneck in phenotyping. Mutants or knockouts of
almost every gene in the C. elegans genome are available by order
from repositories, and this opens up many exciting opportunities
for mapping genes to function, as well as identifying new targets
for human disease or novel anthelmintics (we have argued above
that the potential for speed of discovery in the free living C. elegans
is expected to compensate, at least partly, for its limitations as a
model of parasitic species). In contrast, behavioural phenotyping
is no faster and may even be slower, than that seen in studies of
mice, and usually consists of subjective descriptors, with no
rigorous deﬁnitions of such terms whose meaning is enshrined in
community consensus. Although other scorable behavioural phe-
notypic assays exist, such as pharyngeal pumping (Jadhav and
Rajini, 2009), the swimming assay (see above) remains the most
widely accepted phenotypic scoring method.
Several laboratories, some from an engineering background and
others from a ‘‘worm’’ background, have tackled the problem of
automating worm (C. elegans) phenotyping. Most use well-estab-
lished, machine-vision approaches (foreground segmentation,
binarization, skeletonisation, etc.), often coupled with machine-
learning algorithms that use supervised or unsupervised (e.g. clus-
tering) methods to quantify behaviour. One such example is Nemo,
which takes moving images of worms on plates coated with an
agar-based growth medium and calculates several parameters of
worm shape. Nemo has a graphical user interface and yields high
resolution data (Tsibidis and Tavernarakis, 2007). Cronin et al.
(2005) report another system following similar principles.
A major breakthrough in automation has been the development
of low-cost, automated tracking microscopes, allowing the assem-
bly of a behavioural database for 305 C. elegans strains byWR Scha-
fer and colleagues (Yemini et al., 2013). This includes 76 mutants
with no previously described phenotype. The database consists of
9203 short videos of individual worms segmented to extract
behavioural and morphological features. The resource is accessible
on line and data are available for further analysis. The authors have
included summary statistics for 702 measures with statistical com-
parisons to wild-type controls so that phenotypes can be identiﬁed
and understood by users. Among the many possible beneﬁcial out-
comes of this work is the development of new algorithms for fea-
ture measurements, some of which could greatly enhance drug
screens.
Recently, the factors inﬂuencing the two kinds of C. elegans for-
aging behaviours (roaming and dwelling) have been explored by
ﬁlming for 90 min at 3 frames/s worms on agar plates seeded with
bacteria (Flavell et al., 2013). Worm trajectories were extracted
from videos using custom scripts that calculated the speed and
angular speed of each animal. Averaging over 10 s intervals, easily
separated roaming and dwelling intervals (Ben Arous et al., 2009)
allowing a description of an animal’s trajectory as a sequence of
roaming and dwelling intervals.
Some systems deserve particular mention for their innovative
nature. Standard, ﬂatbed scanners have been used to develop an
automated lifespan assay (Stroustrup et al., 2013). The authors
placed 16 petri dishes, each with adult worms, in each scanner,
and the images were recorded over time online with a Linux com-
mand-line script. Worm shapes were identiﬁed using an unsuper-
vised classiﬁer that learns from 65 features and by deﬁning dead
worms as those worm-shapes that are not moving, lifespan data
can be generated. It is clear that these high-granular approaches
to phenotyping can be used to generate biologically meaningful
results. For example, individual worms of many differentgenotypes have been tracked on agar plates and their movement
deﬁned using 161 behavioural parameters (Zheng et al., 2012).
The results were analysed using unsupervised clustering
(K-means), which revealed clusters of behavioural genes and many
genes present in the same cluster were also in the same biochem-
ical pathway.
A common feature of many of these systems is the provision of a
detailed description of the evolution of some parameters of worm
shape or position over time. To capture worm movements
adequately, many parameters are often needed to specify each
posture. One can imagine the change in shape over time being rep-
resented by a trajectory through a set of multidimensional
coordinates, each dimension representing one of those shape
parameters. Such a dataset can then be analysed using well-
established pattern-recognition principles such as unsupervised
clustering and the effects of chemicals can therefore be quantiﬁed.
This has exciting potential, because a compound could be effective
as an anthelmintic by affecting some aspect of behaviour that pre-
vents the worm from being reproductively successful, without
immediately killing the worm. However, this approach could only
be of use if it can be deployed robustly in high-throughput screens.
Later on, we address whether this is feasible.
Another distinct advantage offered by C. elegans is the ease of
culture in liquid and manipulation using ﬂuid handling techniques.
This opens up the possibilities of applying microﬂuidic techniques
to developing worm assays, with the prospect of partly overcoming
the limitations of existing methods when applied to high-through-
put assays. A COPAS sorter was used to seed worms and later count
the adults resulting in an assay for worm reproductive capacity
(Boyd et al., 2010). In this case, all handling was automated. A
microﬂuidics approach has been adopted, raising cohorts of 30–
50 worms in each of eight separate chambers on a single ‘‘Worm-
Farm’’ polydimethylsiloxane chip throughout their lifespan (Xian
et al., 2013). Standard computer algorithms detect worm death
as well as behavioural and morphological features.
4.6. Are the algorithms developed for automation sufﬁciently robust
for automated drug/chemical screening?
The simplest approach for a screen is to score the phenotypic
effects of each compound in a library and follow up those with a
score above a statistical threshold – the ‘‘primary hits.’’ This
approach is plagued with false positives, a problem that worsens
as the size of the library increases. However, when an automated
scoring algorithm is fast enough, very large (>100,000 compound)
libraries can be screened allowing more sophisticated aggregated
readouts such as a detailed structure-activity study. In addition,
fast screens make it easier to run several replicates, again minimis-
ing the inﬂuence of false positives. However, several factors have
limited the successful use of these algorithms in high-throughput
screens. Most of them are labour intensive, requiring ﬁlming of
worms on individual plates – indeed most of them require individ-
ual worms to be ﬁlmed or tracked, meaning individual adults have
to be manually picked out and deposited. Even if this could be
automated, the machine vision algorithms used are rarely robust
against variations in the quality of image acquisition. For instance,
many algorithms attempt to separate worm from background
using thresholding. If the illumination is uneven, errors in this step
are almost unavoidable. Most algorithms also perform skeletonisa-
tion – reducing the worm proﬁle to a single, one-pixel wide curve.
Again, this step is notoriously sensitive to the quality of its input,
which in turn is sensitive to binarization, although this can be
partly overcome by using techniques like Gaussian mixture models
to track the evolution of worm shape and location (Mitchell et al.,
2010; Sznitman et al., 2010) or using measures of curvature in

















Fig. 2. Automated measurement of nematode swimming (thrashing) in 96-well plates using a covariance-based statistical approach enables motility measurement suitable
for use in high-throughput drug/chemical screens. (A) The device (Wormwatcher) analyses movement by (B) simultaneously recording movies of worms movement in all
wells of a 96-well plate. The movie is analysed by generating (C) a covariance matrix for each individual well showing the similarity between frames tx and ty. (D) The time
dependence of similarity between pairs of images is used to estimate the time interval between rhythmic worm movements (*), and hence the thrashing rate.
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the user ﬁnds that a lot of adjustments of parameters are needed
to obtain reasonable results.
4.7. Statistical imaging approaches: one way forward for automated
phenotypic screening
In our lab, we attempted to side-step some of the problems
involved in image segmentation that we have highlighted above
by replacing machine vision with an image statistics approach
(Buckingham and Sattelle, 2009). Taking the well-established
swimming assay as amodel, we found that simply taking the covari-
ance of a series of movie frames as an index of image similarity
enabled the computer to count the number of frames that separate
similar images (Fig. 2). This is effectively a crude measure of auto-
correlation, and is remarkably robust against poor image quality
and, critically, the number of worms in the image. We
(Buckingham and Sattelle, 2009) found it yielded very similar
results to manual-scoring (the R2 correlation between the machine
readout and those of 2 independent manual scorers was greater
than 0.9) but took only seconds to perform for a 96-well plate. The
algorithm, developedusing C. elegans, worked (without adjustment)
for the parasitic nematode, H. contortus (Buckingham and Sattelle,
2009), and was able to generate concentration-inhibition curves
demonstrating the effects of the anthelmintic, levamisole, on worm
motility. While the swimming assay is a popular and convenient
way to score motility in C. elegans, crude wormmovement is inade-
quate as an indicator of worm killing in screens for anthelmintics.
Although immobility does not necessarily imply death (there areTable 1
Approaches to automated phenotyping of nematodes and the techniques deployed.
Automation approach Techniques
(A) Tracking Tracking overall
behaviour
Classify discr
Beam interruption Scattering of
NEMO Skeletonisatio
machine visio
(B) Targeting discrete behaviours Automation of foraging Tracking side
Automation of egg laying
Swimming/thrashing Plate-based c
(C) Microﬂuidics Dead worm counting COPAS sorter
Microﬂuidics
(D) Monitoring complete behavioural
repertoire







environmentchemicals that paralyse worms without killing them), a simple
approach to determining how many worms are alive in a high-
throughput context would be to decide where, and how much,
movement is occurring in a suspension of worms. This can be done
by comparing pairs of images taken at a ﬁxed time interval, and
counting the number of pixels that appear to have changed. The
ﬁndings can be normalised for the number of worms in the well,
or, more simply, can be normalised to the pixel count in each well
before compounds have been added.
By ﬁlming T. muris for 10–20 s and using our own, in-house
software, we calculated the changes in pixels resulting from worm
movement. Results were reproducible between replicates and the
speed of measurements permitted small-scale drug testing (Hurst
et al., 2014) and its potential for high-throughput screening of
chemical libraries is currently being explored. The idea of
movement detection has been taken a step further, using the
Lucas–Kanade algorithm (an established computer-vision method
of providing movement vectors from movie images), and this has
proven successful for drug screening studies on larger (macro)
parasites (Marcellino et al., 2014; Storey et al., 2014). WormAssay
is a 96-well, plate-based, visual imaging system that uses soft-
ware to analyse drug actions on such worms. The authors have
made available their open source software (Marcellino et al.,
2014). The application and source code are available for free
use, modiﬁcation and redistribution under the terms of the GNU
Public Licence, version 2 or later; see http://www.gnu.org/
licences/gpl-2.0.html for details. The application and its
source code can be downloaded from http://code.google.com/p/
wormassay/ (see Table 1).References
ete worm movements using machine vision Shingai (2000)
Hoshi and Shingai (2006)
infra-red beam Simonetta and Golombek
(2007)




-to-side head movements Ramot et al. (2008)
Hardaker et al. (2001)
ovariance method Buckingham and Sattelle
(2009)
Hurst et al. (2014)
Boyd et al. (2010)
Xian et al. (2013)
tracking: multiple morphological and dynamic
s
Baek et al. (2002)
Geng et al. (2003)
Feng et al. (2004)
Cronin et al. (2005)
Yemini et al. (2013)
m trackers Stroustrup et al. (2013)
aging and Lukas–Kanade tracking Marcellino et al. (2014)
d models for phenotyping in complex
s
Greenblum et al. (2014)
S.D. Buckingham et al. / International Journal for Parasitology: Drugs and Drug Resistance 4 (2014) 226–232 2315. Conclusions
Rapid progress is beingmade in automating the analysis of nem-
atode movement. Much of this effort has yielded computer pro-
grams that produce impressive results in identifying aspects of
nematode movement and the roles played by genes and gene clus-
ters in worm behaviour. However, for the most part, these research
programmes have not had the requirements of high-throughput
drug/chemical discovery in their sights. They are necessarily
labour-intensive and can be very susceptible to inconsistencies in
the experimental setup (such as changes in lighting).
How might these advances help us use automated phenotypic
screens to ﬁnd new anthelmintics? Large-scale, rapid phenotypic
screening needs three elements to be in place. First, it needs model
material (worms) that can be handled in large volumes by
machines. Secondly, it requires an automatic readout that is simple
(either scalar or low-dimensional vector) to interpret. Thirdly, it
should be robust against variability in recording, since the need
for intense manual curation would undermine speed. The ﬁrst is
met by C. elegans, a free-living nematode and genetic model organ-
ism as well as by some cultured or harvested parasitic worms, such
as H. contortus,which are small and tough enough to be handled by
ﬂuidics or even microﬂuidics. The second and third are being met
by algorithms that do not attempt to capture high-dimensional,
ﬁne-grained features of worm movement, but rather adopt proxi-
mal measures (such as a summary of movement vectors or the sta-
tistical comparison of image frames) that are largely orthogonal to
the varying features of the image itself – the Lucas–Kanade algo-
rithm, for example, would be little affected by changing the light
intensity between images, and our covariance approach is com-
pletely unaffected by having a noisy background.
These considerations point to a possible roadmap for the devel-
opment of automated, behavioural screens that can be used to
speed up anthelmintic discovery by an order of magnitude. This
roadmap has two branches. First, algorithms for extracting simple
measures of worm motility from moving images (recorded or live)
need to be developed. The most promising appear to be measures
that infer the average magnitude of movement (Lucas–Kanade,
number of pixel changes) or those that provide a more general
statistical measure of the differences between successive images.
Secondly, methods for the automated handling of worms need to
be developed. Microﬂuidics is used routinely with cells and could
be used, as is, with smaller worms but adaptations to the appropri-
ate scale needed for the handling of larger nematodes are still
required.
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